Activating mutations of the NRAS and BRAF genes occur in ∼20 and 50% of malignant melanomas respectively, and are almost always mutually exclusive (Omholt et al.,2003; Garnett and Marais,2004). The gene discussed is BRAF; the disease is melanoma.